• <em>SCN1A</em> Channels a Wide Range of Epileptic Phenotypes: Report of Novel and Known Variants with Variable Presentations
• A disease similarity approach identifies short-lived Niemann-Pick type C disease mice with accelerated brain aging as a novel mouse model for Alzheimer's disease and aging research
• A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively Stable
• A novel <em>MAPT</em> variant (E342K) as a cause of familial progressive supranuclear palsy
• A systematic review on the biochemical threshold of mitochondrial genetic variants
• Aberrant migration features in primary skin fibroblasts of Huntington's disease patients hold potential for unraveling disease progression using an image based machine learning tool
• Adaptive immune changes associate with clinical progression of Alzheimer's disease
• Ageing-related tau astrogliopathy severely affecting the substantia nigra
• Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice
• Alzheimer's disease and epilepsy: Research hotspots for comorbidity in the era of global aging
• Amyloid-beta peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome
• An autopsy case of type A FTLD-TDP with a GRN mutation presenting with the logopenic variant of primary progressive aphasia at onset and with corticobasal syndrome subsequently
• An exploratory analysis of routine ferritin measurement upon admission and the prognostic implications of low-grade ferritinemia during inflammation
• Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study
• APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease
• Association between Female Reproductive Factors and Risk of Dementia
• Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome
• Behavioral and dysexecutive variant of Alzheimer's disease: Insights from structural and molecular imaging studies
• Behavioral and histological analyses of the mouse <em>Bassoon</em> p.P3882A mutation corresponding to the human <em>BSN</em> p.P3866A mutation
• Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis
• Capgras syndrome in children and adolescents: A systematic review
• Cerebrovascular disease emerges with age and Alzheimer's disease in adults with Down syndrome
• Chronic Traumatic Encephalopathy
• Clinical and morphologic characterization of Pick's dementia: case report and review of the literature
• Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy
• Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome
• Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease
• Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
• Comorbid neuropathology and atypical presentation of Alzheimer's disease
• Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
• Comparison of the Amyloid Plaque Proteome in Down Syndrome, Early-Onset Alzheimer's Disease and Late-Onset Alzheimer's Disease
• Computer vision syndrome among Sudanese medical students: a growing medical issue in the digital world
• Correlating hippocampal and amygdala volumes with neuropathological burden in neurodegenerative diseases using 7T postmortem MRI
• Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis
• Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRI
• Cryo-EM Structures Reveal Tau Filaments from Down Syndrome Adopt Alzheimer's Disease Fold
• Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold
• Cytoarchitectonic gradients of laminar degeneration in behavioral variant frontotemporal dementia
• Cytoarchitectonic gradients of laminar degeneration in behavioural variant frontotemporal dementia
• Default mode network tau predicts future clinical decline in atypical early Alzheimer's disease
• Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer's disease: a real-world study
• Diagnostic and predictive power of plasma proteins in Alzheimer's disease: a cross-sectional and longitudinal study in China
• Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia
• Differential Synaptic Loss in beta-Amyloid Positive Versus beta-Amyloid Negative Corticobasal Syndrome
• Disruption in functional networks mediated tau spreading in Alzheimer's disease
• Effect of Computer-Assisted Cognitive Remediation Therapy on Cognition among Patients with Schizophrenia: A Pilot Randomized Controlled Trial
• Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial
• Eg5 and Diseases: From the Well-Known Role in Cancer to the Less-Known Activity in Noncancerous Pathological Conditions
• Euonymus hamiltonianus Extract Improves Amnesia in APPswe/Tau Transgenic and Scopolamine-Induced Dementia Models
• Evaluation of Neurodegenerative Disorders with Amyloid-beta, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls
• Exercise4Psychosis: A randomised control trial assessing the effect of moderate-to-vigorous exercise on inflammatory biomarkers and negative symptom profiles in men with first-episode psychosis
• Exploring the relationship between cleft type and speech outcome in 4-to-6-year-olds with non-syndromic cleft palate using different measures: A preliminary report
• Fluoxetine attenuates chlorpyrifos-induced neuronal injury through the PPARγ, SIRT1, NF-κB, and JAK1/STAT3 signals
• Foot and Ankle MRI Findings in Asymptomatic Professional Ballet Dancers
• From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach
• gamma-Secretase Modulator BPN15606 Reduced Abeta42 and Abeta40 and Countered Alzheimer-Related Pathologies in a Mouse Model of Down Syndrome
• Genome wide association study of clinical duration and age at onset of sporadic CJD
• GSK3: A potential target and pending issues for treatment of Alzheimer's disease
• Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants
• How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
• In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy
• Induction of tau pathology and motor dysfunction in mice by urinary exosomes from progressive supranuclear palsy patients
• Insulin resistance as the molecular link between diabetes and Alzheimer's disease
• Is preexisting inflamed jaw marrow a "hidden" co-morbidity affecting outcomes of COVID-19 infections? - Clinical comparative study
• Long COVID Brain Fog Treatment: Findings from a Pilot Randomized Controlled Trial of Constraint-Induced Cognitive Therapy
• Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry
• Mechanistic Insights of Neuroprotective Efficacy of Verapamil-Loaded Carbon Quantum Dots against LPS-Induced Neurotoxicity in Rats
• Morning light treatment for inflammatory bowel disease: a clinical trial
• mTBI Biological Biomarkers as Predictors of Postconcussion Syndrome-Review
• Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers
• Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2: preliminary findings
• Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework
• Online acceptance and commitment therapy (iACT) for adults with persistent physical symptoms - 3-month follow-up study of a randomized controlled trial
• Optic Nerve T2 Signal Intensity and Caliber Reflect Clinical Severity in Genetic Optic Atrophy
• Parent-reported genetic counselor adherence to the NSGC practice resource for communicating a potential prenatal diagnosis: Impact on the Down syndrome diagnosis experience
• Parkinson's disease with anxiety: clinical characteristics and their correlation with oxidative stress, inflammation, and pathological proteins
• Pick's Disease Presenting as Tremulous Parkinsonism with Limited Levodopa Response-A Rare Cause of Corticobasal Syndrome
• Polymerase I as a Target for Treating Neurodegenerative Disorders
• Prevalence of Pancreatic Steatosis and Its Associated Factors in Turkey: A Nation-Wide Multicenter Study
• Primary lateral sclerosis associated with PSEN1 Pro284Leu variant in a Colombian family: Clinical and neuropathological features
• Progressive Supranuclear Palsy Syndrome: An Overview
• Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies
• Promoting Growth in Behavioral Neurology: A Path Forward
• Pterostilbene Ameliorates Cognitive Impairment in Polycystic Ovary Syndrome Rat Model through Improving Insulin Resistance via the IRS-1/PI3K/Akt/GSK-3beta Pathway: A Comparative Study with Metformin
• Quetiapine attenuates cadmium neurotoxicity by suppressing oxidative stress, inflammation, and pyroptosis
• Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau PET Tracers in Nuclear Medicine
• RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator trial evaluating three interventions for cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC)
• Reduction of spermine synthase enhances autophagy to suppress Tau accumulation
• Relationships between PET and blood plasma biomarkers in corticobasal syndrome
• Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
• Serum Markers of Neurodegeneration Are Strongly Linked to Heart Failure Severity and Outcome
• Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies
• The associations between common neuroimaging parameters of Progressive Supranuclear Palsy in magnetic resonance imaging and non-specific inflammatory factors - pilot study
• The clinical course of individuals with 22q11.2 deletion syndrome converting to psychotic disorders: a long-term retrospective follow-up
• Traditional Chinese herbal medicine retention enema combined with perineal massage (THREM): a promising therapeutic strategy for refractory chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
• Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases
• Using weight-for-age as a screening tool for metabolic syndrome in apparently healthy adolescents
• Validation of a German version of the dementia screening questionnaire for individuals with intellectual disabilities (DSQIID-G) in Down's syndrome
• Whole-body magnetic resonance neurography in patients with chronic inflammatory demyelinating polyneuropathy
• γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)